In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease

Veljko Veljkovic, Marco Goeijenbier, Sanja Glisic, Nevena Veljkovic, Vladimir R. Perovic, Milan Sencanski, Donald R. Branch, Slobodan Paessler

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The large 2014/2015 Ebola virus outbreak in West Africa points out the urgent need to develop new preventive and therapeutic approaches that are effective against Ebola viruses and can be rapidly utilized. Recently, a simple theoretical criterion for the virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection was proposed. Using this method the 'drug space' was screened and 267 approved and 382 experimental drugs as candidates for treatment of the Ebola virus disease (EVD) have been selected. Detailed analysis of these drugs revealed the non-steroidal anti-inflammatory drug ibuprofen as an inexpensive, widely accessible and minimally toxic candidate for prevention and treatment of EVD. Furthermore, the molecular mechanism underlying this possible protective effect of ibuprofen against EVD is suggested in this article.

Original languageEnglish (US)
Article number104
JournalF1000Research
Volume4
DOIs
StatePublished - May 1 2015

Fingerprint

Ebola Hemorrhagic Fever
Ibuprofen
Virus Diseases
Viruses
Computer Simulation
Ebolavirus
Pharmaceutical Preparations
Western Africa
Poisons
Disease Outbreaks
Anti-Inflammatory Agents
Screening

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease. / Veljkovic, Veljko; Goeijenbier, Marco; Glisic, Sanja; Veljkovic, Nevena; Perovic, Vladimir R.; Sencanski, Milan; Branch, Donald R.; Paessler, Slobodan.

In: F1000Research, Vol. 4, 104, 01.05.2015.

Research output: Contribution to journalArticle

Veljkovic, V, Goeijenbier, M, Glisic, S, Veljkovic, N, Perovic, VR, Sencanski, M, Branch, DR & Paessler, S 2015, 'In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease', F1000Research, vol. 4, 104. https://doi.org/10.12688/f1000research.6436.1
Veljkovic, Veljko ; Goeijenbier, Marco ; Glisic, Sanja ; Veljkovic, Nevena ; Perovic, Vladimir R. ; Sencanski, Milan ; Branch, Donald R. ; Paessler, Slobodan. / In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease. In: F1000Research. 2015 ; Vol. 4.
@article{3ffcc4bd1ca14af58aa4a8ebe0f09c0a,
title = "In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease",
abstract = "The large 2014/2015 Ebola virus outbreak in West Africa points out the urgent need to develop new preventive and therapeutic approaches that are effective against Ebola viruses and can be rapidly utilized. Recently, a simple theoretical criterion for the virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection was proposed. Using this method the 'drug space' was screened and 267 approved and 382 experimental drugs as candidates for treatment of the Ebola virus disease (EVD) have been selected. Detailed analysis of these drugs revealed the non-steroidal anti-inflammatory drug ibuprofen as an inexpensive, widely accessible and minimally toxic candidate for prevention and treatment of EVD. Furthermore, the molecular mechanism underlying this possible protective effect of ibuprofen against EVD is suggested in this article.",
author = "Veljko Veljkovic and Marco Goeijenbier and Sanja Glisic and Nevena Veljkovic and Perovic, {Vladimir R.} and Milan Sencanski and Branch, {Donald R.} and Slobodan Paessler",
year = "2015",
month = "5",
day = "1",
doi = "10.12688/f1000research.6436.1",
language = "English (US)",
volume = "4",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease

AU - Veljkovic, Veljko

AU - Goeijenbier, Marco

AU - Glisic, Sanja

AU - Veljkovic, Nevena

AU - Perovic, Vladimir R.

AU - Sencanski, Milan

AU - Branch, Donald R.

AU - Paessler, Slobodan

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The large 2014/2015 Ebola virus outbreak in West Africa points out the urgent need to develop new preventive and therapeutic approaches that are effective against Ebola viruses and can be rapidly utilized. Recently, a simple theoretical criterion for the virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection was proposed. Using this method the 'drug space' was screened and 267 approved and 382 experimental drugs as candidates for treatment of the Ebola virus disease (EVD) have been selected. Detailed analysis of these drugs revealed the non-steroidal anti-inflammatory drug ibuprofen as an inexpensive, widely accessible and minimally toxic candidate for prevention and treatment of EVD. Furthermore, the molecular mechanism underlying this possible protective effect of ibuprofen against EVD is suggested in this article.

AB - The large 2014/2015 Ebola virus outbreak in West Africa points out the urgent need to develop new preventive and therapeutic approaches that are effective against Ebola viruses and can be rapidly utilized. Recently, a simple theoretical criterion for the virtual screening of molecular libraries for candidate inhibitors of Ebola virus infection was proposed. Using this method the 'drug space' was screened and 267 approved and 382 experimental drugs as candidates for treatment of the Ebola virus disease (EVD) have been selected. Detailed analysis of these drugs revealed the non-steroidal anti-inflammatory drug ibuprofen as an inexpensive, widely accessible and minimally toxic candidate for prevention and treatment of EVD. Furthermore, the molecular mechanism underlying this possible protective effect of ibuprofen against EVD is suggested in this article.

UR - http://www.scopus.com/inward/record.url?scp=84936952565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936952565&partnerID=8YFLogxK

U2 - 10.12688/f1000research.6436.1

DO - 10.12688/f1000research.6436.1

M3 - Article

VL - 4

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 104

ER -